The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cholangitis, Sclerosing

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cholangitis, Sclerosing


High impact information on Cholangitis, Sclerosing


Chemical compound and disease context of Cholangitis, Sclerosing


Biological context of Cholangitis, Sclerosing


Anatomical context of Cholangitis, Sclerosing


Gene context of Cholangitis, Sclerosing


Analytical, diagnostic and therapeutic context of Cholangitis, Sclerosing


  1. The biliary system in primary biliary cirrhosis. A study by endoscopic retrograde cholangiopancreatography. Summerfield, J.A., Elias, E., Hungerford, G.D., Nikapota, V.L., Dick, R., Sherlock, S. Gastroenterology (1976) [Pubmed]
  2. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Pardi, D.S., Loftus, E.V., Kremers, W.K., Keach, J., Lindor, K.D. Gastroenterology (2003) [Pubmed]
  3. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Ishimura, N., Bronk, S.F., Gores, G.J. Gastroenterology (2005) [Pubmed]
  4. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Seibold, F., Slametschka, D., Gregor, M., Weber, P. Gastroenterology (1994) [Pubmed]
  5. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Lindor, K.D. N. Engl. J. Med. (1997) [Pubmed]
  6. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. Eksteen, B., Grant, A.J., Miles, A., Curbishley, S.M., Lalor, P.F., Hübscher, S.G., Briskin, M., Salmon, M., Adams, D.H. J. Exp. Med. (2004) [Pubmed]
  7. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Fickert, P., Wagner, M., Marschall, H.U., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M.P., Cover, C., Denk, H., Hofmann, A.F., Jaeschke, H., Trauner, M. Gastroenterology (2006) [Pubmed]
  8. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Olsson, R., Boberg, K.M., de Muckadell, O.S., Lindgren, S., Hultcrantz, R., Folvik, G., Bell, H., Gangsøy-Kristiansen, M., Matre, J., Rydning, A., Wikman, O., Danielsson, A., Sandberg-Gertzén, H., Ung, K.A., Eriksson, A., Lööf, L., Prytz, H., Marschall, H.U., Broomé, U. Gastroenterology (2005) [Pubmed]
  9. A patient with primary sclerosing cholangitis ponders pulse: methotrexate paper. Wyman, D.R. Gastroenterology (1994) [Pubmed]
  10. Prospective trial of penicillamine in primary sclerosing cholangitis. LaRusso, N.F., Wiesner, R.H., Ludwig, J., MacCarty, R.L., Beaver, S.J., Zinsmeister, A.R. Gastroenterology (1988) [Pubmed]
  11. Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy. Rodman, C.A., Keeffe, E.B., Lieberman, D.A., Krishnamurthy, S., Krishnamurthy, G.T., Gilbert, S., Eklem, M.J. Gastroenterology (1987) [Pubmed]
  12. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Bruggraber, S.F., Leung, P.S., Amano, K., Quan, C., Kurth, M.J., Nantz, M.H., Benson, G.D., Van de Water, J., Luketic, V., Roche, T.E., Ansari, A.A., Coppel, R.L., Gershwin, M.E. Gastroenterology (2003) [Pubmed]
  13. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Satsangi, J., Chapman, R.W., Haldar, N., Donaldson, P., Mitchell, S., Simmons, J., Norris, S., Marshall, S.E., Bell, J.I., Jewell, D.P., Welsh, K.I. Gastroenterology (2001) [Pubmed]
  14. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Wiencke, K., Spurkland, A., Schrumpf, E., Boberg, K.M. Hepatology (2001) [Pubmed]
  15. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. Donaldson, P.T., Norris, S., Constantini, P.K., Bernal, W., Harrison, P., Williams, R. J. Hepatol. (2000) [Pubmed]
  16. The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease. Minuk, G.Y., Paul, R.W., Lee, P.W. J. Med. Virol. (1985) [Pubmed]
  17. Tissue distribution of autoantigen specific for primary sclerosing cholangitis. Lo, S.K., Chapman, R.W., Fleming, K.A. J. Clin. Pathol. (1993) [Pubmed]
  18. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Lebovics, E., Salama, M., Elhosseiny, A., Rosenthal, W.S. Gastroenterology (1992) [Pubmed]
  19. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Mehal, W.Z., Lo, Y.M., Wordsworth, B.P., Neuberger, J.M., Hubscher, S.C., Fleming, K.A., Chapman, R.W. Gastroenterology (1994) [Pubmed]
  20. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hayashi, N., Yamamoto, H., Hiraoka, N., Dono, K., Ito, Y., Okami, J., Kondo, M., Nagano, H., Umeshita, K., Sakon, M., Matsuura, N., Nakamori, S., Monden, M. Hepatology (2001) [Pubmed]
  21. Hepatobiliary toxicity of 5-fluoro-2'-deoxyuridine. Intra-arterial versus portal venous routes of infusion. Andrews, J.C., Kuntsen, C., Terio, P., Priescorn, D., Ensminger, W.D. Investigative radiology. (1991) [Pubmed]
  22. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Hashimoto, E., Lindor, K.D., Homburger, H.A., Dickson, E.R., Czaja, A.J., Wiesner, R.H., Ludwig, J. Mayo Clin. Proc. (1993) [Pubmed]
  23. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Endo, K., Yoon, B.I., Pairojkul, C., Demetris, A.J., Sirica, A.E. Hepatology (2002) [Pubmed]
  24. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Vogel, A., Liermann, H., Harms, A., Strassburg, C.P., Manns, M.P., Obermayer-Straub, P. Hepatology (2001) [Pubmed]
  25. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Pauli-Magnus, C., Kerb, R., Fattinger, K., Lang, T., Anwald, B., Kullak-Ublick, G.A., Beuers, U., Meier, P.J. Hepatology (2004) [Pubmed]
  26. Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. Bisgaard, H.C., Holmskov, U., Santoni-Rugiu, E., Nagy, P., Nielsen, O., Ott, P., Hage, E., Dalhoff, K., Rasmussen, L.J., Tygstrup, N. Am. J. Pathol. (2002) [Pubmed]
  27. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. Girodon, E., Sternberg, D., Chazouillères, O., Cazeneuve, C., Huot, D., Calmus, Y., Poupon, R., Goossens, M., Housset, C. J. Hepatol. (2002) [Pubmed]
  28. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A.H., Lammert, F., Marschall, H.U., Tsybrovskyy, O., Zatloukal, K., Denk, H., Trauner, M. Gastroenterology (2002) [Pubmed]
  29. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Duerr, R.H., Targan, S.R., Landers, C.J., LaRusso, N.F., Lindsay, K.L., Wiesner, R.H., Shanahan, F. Gastroenterology (1991) [Pubmed]
  30. Quality of life before and after liver transplantation for cholestatic liver disease. Gross, C.R., Malinchoc, M., Kim, W.R., Evans, R.W., Wiesner, R.H., Petz, J.L., Crippin, J.S., Klintmalm, G.B., Levy, M.F., Ricci, P., Therneau, T.M., Dickson, E.R. Hepatology (1999) [Pubmed]
  31. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Katsuma, Y., Swierenga, S.H., Khettry, U., Marceau, N., French, S.W. Hepatology (1987) [Pubmed]
  32. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Poonawala, A., Nair, S.P., Thuluvath, P.J. Hepatology (2000) [Pubmed]
WikiGenes - Universities